Clinicopathologic and metabolic variables from 18F-FDG PET/CT in the prediction of recurrence pattern in stage I–III non-small cell lung cancer after curative surgery
- 13 February 2025
- journal article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 39 (5) , 476-505
Abstract
This study aimed to analyze the clinicopathologic and metabolic parameters derived from staging 18F-FDG PET/CT that can predict recurrence patterns in non-small-cell lung cancer (NSCLC) after curative surgery. Retrospective study included stage I-III NSCLC patients with a baseline 18F-FDG PET/CT scan. Relapse patterns were analyzed based on location, lesion, and organ-specific recurrence. Clinicopathologic variables were recorded. Three distinct categories of variables were obtained: standardized uptake value (SUV)-based metrics, heterogeneity parameters, and morphological features. The relation of relapse patterns with clinicopathologic and metabolic parameters was analyzed using the uni-multivariate logistic regression. Out of 173 patients, 104 experienced recurrences, with 66% presenting distant involvement and 56.7% exhibiting polymetastatic disease at initial recurrence. Patient age, pathologic lymphovascular invasion, and normalized SUVmax perimeter distance (nSPD) were considered as risk factors for early recurrence. Adenocarcinoma histology was identified as an independent variable for distant recurrence. Patient age, number of metastatic mediastinal lymph nodes at staging (nN), sphericity, normalized SUVpeak to centroid distance (nSCD), entropy, low gray-level run emphasis, and high gray-level run emphasis were independent variables for polymetastatic disease. Certain variables were correlated with organ-specific recurrence. Bone recurrence was related to nN and SUVmean. Brain recurrence was related to adenocarcinoma histology. Lung recurrence was associated with coefficient of variation and nSPD. The metabolic profile of lung primary tumors obtained from 18F-FDG PET/CT seems to be predictive of recurrence patterns that are closely linked to the overall survival of NSCLC patients. These findings could help in the development of personalized follow-up strategies based on an individual's recurrence pattern.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification?Journal of Thoracic Oncology, 2011
- A Clinical Study of the Prognostic Factors for Postoperative Early Recurrence in Patients who Underwent Complete Resection for Pulmonary AdenocarcinomaAnnals of Thoracic and Cardiovascular Surgery, 2011
- Prognostic impact of local treatment against postoperative oligometastases in non‐small cell lung cancerJournal of Surgical Oncology, 2010
- Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasisThorax, 2010
- Comparative Chemotherapeutic Efficacy in Non-small Cell Lung Cancer Patients with Postoperative Recurrence and Stage IV DiseaseJournal of Thoracic Oncology, 2009
- Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2008
- Early recurrence of completely resected N2-positive non-small-cell lung cancerGeneral Thoracic and Cardiovascular Surgery, 2007
- Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary ResectionThe Annals of Thoracic Surgery, 2007
- Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs.2001
- Multiple primary lung cancers.1975